+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

DelveInsight - Market Research Reports

Delve Insight authors market leading reports across the pharmaceutical and biotechnology sectors. The key findings and insights all come from regular monitoring of developments through the pharmaceutical and biotechnology sectors. These findings are then published through market forecasts, drug pipelines and drug insights, along with advice from top market analysts on how to best use this, alongside the detailed market forecasts offered by Delve Insight.

Non Selective COX Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Non Selective COX Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
G2 Checkpoint Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

G2 Checkpoint Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Fibroblast Growth Factor 1 (FGF-1) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Fibroblast Growth Factor 1 (FGF-1) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Prostaglandin Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Prostaglandin Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Adenosine A2A Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A2A Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A2 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A2 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
CCR4 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CCR4 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Leukotriene D4 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Leukotriene D4 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Leukotriene Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Leukotriene Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2025 - Product Thumbnail Image

Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha-2 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-2 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Muscarinic Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Muscarinic Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Fatty Acid Amide Hydrolase (FAAH) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Fatty Acid Amide Hydrolase (FAAH) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
GABA Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

GABA Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cannabinoid Receptor Type 1 (CB1) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Cannabinoid Receptor Type 1 (CB1) Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pim Kinase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Pim Kinase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
P2X7 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

P2X7 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator